Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Apr-24 5:43 PM View:  | Ingevity Corp (NGVT) | 24-Apr-24 | Grant | 2,800 | -- | -- | 28% 10.14K to 12.94K | |
| 02-May-23 10:00 PM View: | Ingevity Corp (NGVT) | 28-Apr-23 | Grant | 1,645 | -- | -- | 19% 8.49K to 10.14K | |
| 02-Mar-23 7:50 PM View: | Albemarle Corp. (ALB) | 28-Feb-23 | Grant | 6,720 | -- | -- | 61% 10.93K to 17.65K | |
| 02-Mar-23 7:50 PM View: | Albemarle Corp. (ALB) | 28-Feb-23 | Payment of Exercise | 3,755 | $254.31 | $954,934.00 | (19%) 19.33K to 15.57K | |
| 02-Mar-23 7:50 PM View: | Albemarle Corp. (ALB) | 28-Feb-23 | Option Exercise | 1,680 | -- | -- | 10% 17.65K to 19.33K | |
| 28-Feb-23 10:00 PM View: | Albemarle Corp. (ALB) | 26-Feb-23 | Payment of Exercise | 646 | $249.52 | $161,190.00 | (6%) 11.57K to 10.93K | |
| 28-Feb-23 10:00 PM View: | Albemarle Corp. (ALB) | 26-Feb-23 | Option Exercise | 1,443 | -- | -- | 14% 10.13K to 11.57K | |
| 04-Jan-23 4:58 PM View: | Albemarle Corp. (ALB) | 01-Jan-23 | Payment of Exercise | 1,496 | $216.86 | $324,423.00 | (13%) 11.63K to 10.13K | |
| 04-Jan-23 4:58 PM View: | Albemarle Corp. (ALB) | 01-Jan-23 | Option Exercise | 4,810 | -- | -- | 71% 6.82K to 11.63K | |
| 01-Dec-22 5:28 PM View: | Albemarle Corp. (ALB) | 01-Dec-22 | Private Sale (Planned) | 2,250 | $280.25 | $630,562.00 | (25%) 9.06K to 6.82K | |
| 14-Nov-22 6:42 AM View: | Albemarle Corp. (ALB) | 11-Nov-22 | Option Exercise | 6,135 | $63.84 | $391,658.00 | 51% 12.0K to 18.14K | |
| 14-Nov-22 6:42 AM View: | Albemarle Corp. (ALB) | 11-Nov-22 | Option Sale | 6,135 | $322.26 | $1,977,070.00 | (34%) 18.14K to 12.0K | |
| 14-Nov-22 6:42 AM View: | Albemarle Corp. (ALB) | 11-Nov-22 | Sale | 2,937 | $322.26 | $946,478.00 | (24%) 12.0K to 9.06K | |
| 01-Nov-22 4:28 PM View: | Albemarle Corp. (ALB) | 01-Nov-22 | Private Sale (Planned) | 2,250 | $285.66 | $642,735.00 | (16%) 14.25K to 12.0K | |
| 03-Oct-22 5:05 PM View: | Albemarle Corp. (ALB) | 03-Oct-22 | Private Sale (Planned) | 2,250 | $270.75 | $609,188.00 | (14%) 16.5K to 14.25K | |
| 05-Oct-22 10:56 AM View: | Ingevity Corp (NGVT) | 03-Oct-22 | Grant | 362 | $62.20 | $22,516.40 | 4% 8.13K to 8.49K | |
| 06-Sep-22 4:31 PM View: | Albemarle Corp. (ALB) | 06-Sep-22 | Private Sale (Planned) | 2,250 | $268.99 | $605,228.00 | (12%) 18.75K to 16.5K | |
| 06-Jul-22 9:00 AM View: | Ingevity Corp (NGVT) | 01-Jul-22 | Grant | 355 | $63.47 | $22,531.80 | 5% 7.78K to 8.13K | |
| 02-May-22 2:37 PM View: | Ingevity Corp (NGVT) | 28-Apr-22 | Grant | 1,942 | -- | -- | 33% 5.83K to 7.78K | |
| 05-Apr-22 2:17 PM View: | Ingevity Corp (NGVT) | 01-Apr-22 | Grant | 347 | $64.91 | $22,523.80 | 6% 5.49K to 5.83K | |
| 28-Feb-22 5:39 PM View: | Albemarle Corp. (ALB) | 26-Feb-22 | Payment of Exercise | 646 | $191.95 | $124,000.00 | (3%) 19.39K to 18.75K | |
| 28-Feb-22 5:39 PM View: | Albemarle Corp. (ALB) | 26-Feb-22 | Option Exercise | 1,443 | -- | -- | 8% 17.95K to 19.39K | |
| 28-Feb-22 5:39 PM View: | Albemarle Corp. (ALB) | 24-Feb-22 | Payment of Exercise | 2,152 | $184.20 | $396,398.00 | (11%) 20.1K to 17.95K | |
| 28-Feb-22 5:39 PM View: | Albemarle Corp. (ALB) | 24-Feb-22 | Option Exercise | 4,810 | -- | -- | 31% 15.29K to 20.1K | |
| 25-Feb-22 10:00 PM View: | Albemarle Corp. (ALB) | 23-Feb-22 | Payment of Exercise | 471 | $182.00 | $85,722.00 | (3%) 15.77K to 15.29K | |
| 25-Feb-22 10:00 PM View: | Albemarle Corp. (ALB) | 23-Feb-22 | Option Exercise | 1,053 | -- | -- | 7% 14.71K to 15.77K | |
| 06-Jan-22 4:47 PM View: | Albemarle Corp. (ALB) | 05-Jan-22 | Market Sale (Planned) | 2,308 | $239.94 | $553,782.00 | (14%) 17.02K to 14.71K | 2% |
| 28-Jan-22 2:37 PM View: | Ingevity Corp (NGVT) | 03-Jan-22 | Grant | 301 | $74.85 | $22,529.80 | 6% 5.19K to 5.49K | 5% |
| 04-Jan-22 4:48 PM View: | Albemarle Corp. (ALB) | 01-Jan-22 | Payment of Exercise | 1,283 | $233.77 | $299,927.00 | (7%) 18.3K to 17.02K | |
| 04-Jan-22 4:48 PM View: | Albemarle Corp. (ALB) | 01-Jan-22 | Option Exercise | 4,212 | -- | -- | 30% 14.09K to 18.3K | |
| 04-Jan-22 4:48 PM View: | Albemarle Corp. (ALB) | 31-Dec-21 | Payment of Exercise | 1,366 | $233.77 | $319,330.00 | (9%) 15.46K to 14.09K | |
| 04-Jan-22 4:48 PM View: | Albemarle Corp. (ALB) | 31-Dec-21 | Option Exercise | 3,055 | -- | -- | 25% 12.4K to 15.46K | |
| 08-Dec-21 4:40 PM View: | Albemarle Corp. (ALB) | 08-Dec-21 | Market Sale (Planned) | 1,337 | $261.00 | $348,957.00 | (10%) 13.74K to 12.4K | < 1% |
| 15-Nov-21 10:00 PM View: | Albemarle Corp. (ALB) | 12-Nov-21 | Market Sale | 3,675 | $270.94 | $995,693.00 | (21%) 17.41K to 13.74K | (< 1%) |
| 08-Nov-21 4:43 PM View: | Albemarle Corp. (ALB) | 08-Nov-21 | Market Sale (Planned) | 1,337 | $275.80 | $368,745.00 | (7%) 18.75K to 17.41K | 1% |
| 12-Oct-21 8:59 AM View: | Albemarle Corp. (ALB) | 08-Oct-21 | Market Sale (Planned) | 1,337 | $221.98 | $296,787.00 | (7%) 20.09K to 18.75K | 4% |
| 08-Sep-21 5:22 PM View: | Albemarle Corp. (ALB) | 08-Sep-21 | Market Sale (Planned) | 1,337 | $243.75 | $325,894.00 | (6%) 21.42K to 20.09K | 2% |
| 13-Aug-21 10:00 PM View: | Albemarle Corp. (ALB) | 13-Aug-21 | Market Sale | 8,811 | $235.09 | $2,071,350.00 | (29%) 30.23K to 21.42K | (< 1%) |
| 09-Aug-21 4:21 PM View: | Albemarle Corp. (ALB) | 09-Aug-21 | Market Sale (Planned) | 1,338 | $224.71 | $300,662.00 | (4%) 31.57K to 30.23K | (< 1%) |
| 09-Aug-21 4:21 PM View: | Albemarle Corp. (ALB) | 06-Aug-21 | Market Sale | 10,000 | $216.12 | $2,161,150.00 | (24%) 41.57K to 31.57K | (5%) |
| 08-Jul-21 4:34 PM View: | Albemarle Corp. (ALB) | 08-Jul-21 | Market Sale (Planned) | 1,338 | $165.69 | $221,693.00 | (3%) 42.91K to 41.57K | (3%) |
| 09-Jun-21 4:17 PM View: | Albemarle Corp. (ALB) | 08-Jun-21 | Market Sale (Planned) | 1,338 | $171.30 | $229,199.00 | (3%) 44.25K to 42.91K | (3%) |
| 28-May-21 5:18 PM View: | Albemarle Corp. (ALB) | 27-May-21 | Option Exercise | 6,135 | $63.84 | $391,658.00 | 14% 44.25K to 50.38K | |
| 28-May-21 5:18 PM View: | Albemarle Corp. (ALB) | 27-May-21 | Market Option Sale | 6,135 | $164.76 | $1,010,800.00 | (12%) 50.38K to 44.25K | |
| 27-Apr-21 9:24 AM View: | Ingevity Corp (NGVT) | 23-Apr-21 | Grant | 1,440 | -- | -- | 38% 3.75K to 5.19K | |
| 02-Mar-21 5:49 PM View: | Albemarle Corp. (ALB) | 02-Mar-21 | Market Sale (Planned) | 1,478 | $153.89 | $227,449.00 | (3%) 45.72K to 44.24K | (4%) |
| 01-Mar-21 5:23 PM View: | Albemarle Corp. (ALB) | 01-Mar-21 | Market Option Sale (Planned) | 425 | $160.05 | $68,021.20 | (< 1%) 46.15K to 45.72K | < 1% |
| 01-Mar-21 5:23 PM View: | Albemarle Corp. (ALB) | 26-Feb-21 | Market Option Sale (Planned) | 361 | $152.98 | $55,225.80 | (< 1%) 46.51K to 46.15K | (5%) |
| 01-Mar-21 5:23 PM View: | Albemarle Corp. (ALB) | 25-Feb-21 | Payment of Exercise | 1,255 | $153.48 | $192,617.00 | (3%) 47.76K to 46.51K | (4%) |
| 01-Mar-21 5:23 PM View: | Albemarle Corp. (ALB) | 25-Feb-21 | Option Exercise | 4,212 | -- | -- | 10% 43.55K to 47.76K |